Colon polyps secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
Line 76: Line 76:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
​​[[Category:Medicine]]
​​​​
 
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Up-To-Date]]​​
[[Category:Up-To-Date]]
[[Category:Primary care]]

Revision as of 21:01, 29 July 2020

Colon polyps Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Colon polyps from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Colon polyps secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Colon polyps secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Colon polyps secondary prevention

CDC on Colon polyps secondary prevention

Colon polyps secondary prevention in the news

Blogs on Colon polyps secondary prevention

Directions to Hospitals Treating Colon polyps

Risk calculators and risk factors for Colon polyps secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Effective measures for the secondary prevention of colon polyps include surveillance after finding polyps on routine screening. According to guidelines for colonoscopysurveillance after screening and polypectomy by the US Multi-Society Task Force on colorectal cancer, surveillance and screening are more frequent after first or second adenomatous polyps or serrated polyps. Hyperplastic polyps are considered benign and screening remains similar to general population.

Secondary Prevention

  • Effective measures for the secondary prevention of colon polyps include:
    • Surveillance after finding polyps on routine screening
Baseline colonoscopy Recommendation
Hyperplastic polyps Size <10 mm Colonoscopy every 10 years
Adenomatous polyps 1-2 tubular adenomas <10 mm Colonoscopy every 5-10 years
3-10 tubular adenomas <10 mm Colonoscopy every 3 years
>10 adenomas Colonoscopy <3 years
Tubular adenomas ≥10 mm Colonoscopy every 3 years
Villous adenomas Colonoscopy every 3 years
Adenoma with high grade dysplasia Colonoscopy every 3 years
No adenoma after first low-risk adenoma Colonoscopy every 10 years
No adenoma after first high-risk adenoma Colonoscopy every 5 years
Second adenomatous polyps Second low-risk adenoma Colonoscopy after 5 years
High-risk adenoma following low-risk adenoma Colonoscopy every 3 years
Low-risk adenoma following high-risk adenoma Colonoscopy after 5 years
Second high-risk adenoma Colonoscopy every 3 years
 Serrated polyps Sessile serrated polyp(s) <10 mm with no dysplasia Colonoscopy every 5 years
Sessile serrated polyp(s) ≥10 mm  Colonoscopy every 3 years
Sessile serrated polyp with dysplasia  Colonoscopy every 3 years
Traditional serrated adenoma Colonoscopy every 3 years
Serrated polyposis syndrome Colonoscopy every year

References

  1. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR (2012). "Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer". Gastroenterology. 143 (3): 844–857. doi:10.1053/j.gastro.2012.06.001. PMID 22763141.
  2. National Guideline Clearinghouse (NGC). Guideline summary: Follow-up of colorectal polyps or cancer. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jan 16. [cited 2017 Dec 28]. Available: https://www.guideline.gov
  3. Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson DJ (2017). "Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer". Am. J. Gastroenterol. 112 (7): 1016–1030. doi:10.1038/ajg.2017.174. PMID 28555630.

​​​​